Results 301 to 310 of about 115,017 (359)
Minimally Invasive Left Ventricular Assist Device Implantation: A Systematic Review of Current Evidence on Clinical Outcomes and Surgical Approaches. [PDF]
Turtabayev B +6 more
europepmc +1 more source
Abstract Heart failure (HF) is a growing health and societal challenge in Europe, due to an increasingly elderly, frail and multimorbid population. Many patients with HF experience a high burden of complex and multidimensional symptoms leading to a reduced quality of life and significant socioeconomic impact. Despite proven benefits, the integration of
Tania Pastrana +12 more
wiley +1 more source
Abstract Aims Heart failure (HF) is a major cause of hospitalization, mortality and healthcare costs. Reducing its socioeconomic burden is a key global public health priority. HF networks are recommended to improve screening and management of HF patients.
Christina Paitazoglou +13 more
wiley +1 more source
Worsening versus advanced heart failure: Management and challenges
Clinical feature, circulating biomarkers and therapeutic management of patients with WHF versus AdvHF. Abbreviations: AdvHF, advanced heart failure; HF, heart failure; HTx, heart transplant; GDMT, guideline‐directed medical therapy; MCS, mechanical circulatory support; NYHA, New York Heart Association; WHF, worsening heart failure.
Alberto Palazzuoli +15 more
wiley +1 more source
Mitral regurgitation at the time of left ventricular assist device implantation: Should it be treated or not? [PDF]
Kohno H +4 more
europepmc +1 more source
Abstract Effective medications are available for the prevention of heart failure (HF). While their use is indicated in patients with risk factors, engagement and adherence among ‘at risk’ individuals is challenging, as it is with atherosclerotic heart disease prevention.
Anna Węgrzyn‐Witek +3 more
wiley +1 more source
Candidemia in Left Ventricular Assist Device Recipients: Incidence, Risk Factors, and Outcomes. [PDF]
Anderson R +6 more
europepmc +1 more source
Long‐term prognosis of pure and impure tachycardiomyopathy
Abstract Background and aims Tachycardia‐induced cardiomyopathy (TCM) is a reversible form of heart failure (HF) driven by arrhythmias, often atrial fibrillation (AF). While reversible, TCM's long‐term prognosis remains unclear, especially in comparison to HF with reduced ejection fraction (HFrEF).
Giulia Stronati +11 more
wiley +1 more source
Impact of standardized team‐based care on cardiogenic shock outcomes over time
This contemporary North American cardiogenic shock (CS) registry aimed to investigate the influence of team‐based care on outcomes over a six‐year period of time following implementation of standardized protocols. Despite a two‐fold increase in the number of CS patients and changes in presentation and management strategies, no differences in in ...
Behnam N. Tehrani +24 more
wiley +1 more source
Heart transplantation outcomes with donation after circulatory death in patients with left ventricular assist device. [PDF]
Karatasakis A +13 more
europepmc +1 more source

